Literature DB >> 10334449

Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism.

P F Kantor1, M A Robertson, J Y Coe, G D Lopaschuk.   

Abstract

OBJECTIVES: The purpose of this study was to determine the effect of volume overload hypertrophy in the newborn heart on the cardiac enzymes controlling fatty acid metabolism.
BACKGROUND: Shortly after birth, a rise in 5'-adenosine monophosphate-activated protein kinase (AMPK) activity results in the phosphorylation and inhibition of acetyl coenzyme A (CoA) carboxylase (ACC), and a decline in myocardial malonyl CoA levels with increased fatty acid oxidation rates. Whether the early onset of hypertrophy in the newborn heart alters this maturational increase in fatty acid oxidation is unknown.
METHODS: Newborn piglets underwent endovascular stenting of the ductus arteriosus on day 1 of life with a 4.5-mm diameter stent, resulting in a left to right shunt, and left ventricular (LV) volume loading. Left ventricular and right ventricular samples from fetal, newborn, three-week control and three-week stented animals were compared.
RESULTS: Stenting resulted in echocardiographic evidence of volume overload and myocardial hypertrophy. In control animals, left ventricular ACC activity declined from 274 +/- 30 pmol/mg/min on day 1 to 115 +/- 12 after three weeks (p < 0.05), but did not display this maturation drop in hypertrophied hearts, remaining elevated (270 +/- 50 pmol/mg/min, p < 0.05). At three weeks, malonyl CoA levels remained 2.8-fold higher in hypertrophied hearts than in control hearts. In control hearts, LV AMPK activity increased 178% between day 1 and three weeks, whereas in hypertrophied hearts AMPK activity at three weeks was only 71% of control values, due to a significant decrease in expression of the catalytic subunit of AMPK.
CONCLUSIONS: Early onset LV volume overload with hypertrophy results in a delay in the normal maturation of fatty acid oxidation in the newborn heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334449     DOI: 10.1016/s0735-1097(99)00063-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

Review 2.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

3.  Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency.

Authors:  Lisa de las Fuentes; Pablo F Soto; Brian P Cupps; Michael K Pasque; Pilar Herrero; Robert J Gropler; Alan D Waggoner; Victor G Dávila-Román
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

Review 4.  Imaging of myocardial metabolism.

Authors:  Pilar Herrero; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

Review 5.  Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Authors:  Andrew A Wolff; Heschi H Rotmensch; William C Stanley; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

6.  Gestational hyperglycemia reprograms cardiac gene expression in rat offspring.

Authors:  Lara Lehtoranta; Anna Koskinen; Olli Vuolteenaho; Jukka Laine; Ville Kytö; Hanna Soukka; Eeva Ekholm; Juha Räsänen
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

7.  Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism.

Authors:  Arata Fukushima; Liyan Zhang; Alda Huqi; Victoria H Lam; Sonia Rawat; Tariq Altamimi; Cory S Wagg; Khushmol K Dhaliwal; Lisa K Hornberger; Paul F Kantor; Ivan M Rebeyka; Gary D Lopaschuk
Journal:  JCI Insight       Date:  2018-05-17

8.  Counter-regulatory effects of incremental hypoxia on the transcription of a cardiac fatty acid oxidation enzyme-encoding gene.

Authors:  Kholiswa C Ngumbela; Michael N Sack; M Faadiel Essop
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

9.  Transient activation of p38 MAP kinase and up-regulation of Pim-1 kinase in cardiac hypertrophy despite no activation of AMPK.

Authors:  Biao Lei; David J Chess; Wendy Keung; Karen M O'Shea; Gary D Lopaschuk; William C Stanley
Journal:  J Mol Cell Cardiol       Date:  2008-07-01       Impact factor: 5.000

Review 10.  Return to the fetal gene program protects the stressed heart: a strong hypothesis.

Authors:  Mitra Rajabi; Christos Kassiotis; Peter Razeghi; Heinrich Taegtmeyer
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.